FY2025 EPS Estimates for Krystal Biotech Lowered by Analyst
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Research analysts at Chardan Capital reduced their FY2025 earnings estimates for Krystal Biotech in a research note issued to investors on Wednesday, May 7th. Chardan Capital analyst Y. Livshits now forecasts that the company will post earnings per share of $5.50 for the year, down from their […]
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Research analysts at Chardan Capital reduced their FY2025 earnings estimates for Krystal Biotech in a research note issued to investors on Wednesday, May 7th. Chardan Capital analyst Y. Livshits now forecasts that the company will post earnings per share of $5.50 for the year, down from their […]
